Baxalta US Inc.
- UEI
- LT5GEHL2F1K6
- CAGE
- 7CZJ7
- Primary NAICS
- 325412 Pharmaceutical Preparation Manufacturing
- SAM.gov registration
- Expired
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Baxalta US INC.:1276806 [21-015888] glassia (alpha 1-proteinase inhibitor | NIH Clinical Center | $12,054 | |
| Procurement of pharmaceutical needs. | NIH Clinical Center | $10,332 | |
| Advate 1900 unit vials- QTY. 20 vials | Veterans Integrated Service Network 19 | $26,600 | |
| Ratification for gammagurd ordered 7/6/2020 | Veterans Integrated Service Network 23 | $10,521 | |
| Advate 1900 unit vials | Veterans Integrated Service Network 19 | $13,300 |
About Baxalta US Inc.
Baxalta US Inc. is a foreign owned, for-profit pharmaceutical company that provides drugs and biologics to government agencies through the GSA Pharmaceuticals and Drugs schedule contract. Baxalta specializes in treatments for bleeding disorders, immunodeficiencies, and other rare chronic conditions.
Through prime federal contract awards, Baxalta has provided specialty pharmaceuticals including ADVATE for hemophilia treatment, GAMMAGARD LIQUID immunoglobulin therapy, GLASSIA alpha 1-proteinase inhibitor, and FEIBA anti-inhibitor coagulant complex to the Department of Veterans Affairs, Department of Health and Human Services, Department of Justice Bureau of Prisons, and Defense Logistics Agency. The contract awards have been across multiple Veterans Integrated Service Networks and medical centers, the National Institutes of Health Clinical Center, Federal Correctional Institution Fort Worth, and Federal Medical Center Devens. The contract types have included purchase orders, delivery orders against Baxalta's GSA schedule contract, and IDIQ delivery orders valued up to $600,000. No set aside designations have been used.
Contract vehicles
Quick answers
What is Baxalta US Inc.'s UEI?
Baxalta US Inc.'s Unique Entity ID (UEI) in SAM.gov is LT5GEHL2F1K6.
What is Baxalta US Inc.'s CAGE code?
Baxalta US Inc.'s CAGE code is 7CZJ7.
What is Baxalta US Inc.'s primary NAICS code?
Baxalta US Inc.'s primary NAICS code is 325412 (Pharmaceutical Preparation Manufacturing).
Is Baxalta US Inc. registered in SAM.gov?
Baxalta US Inc.'s SAM.gov registration expired on December 10, 2021.
Which contract vehicles does Baxalta US Inc. hold?
Baxalta US Inc. holds a place on 1 federal contract vehicle: FSS-61-IB.
What is Baxalta US Inc.'s most recent federal award?
Baxalta US Inc.'s most recent federal contract award is Baxalta US INC.:1276806 [21-015888] glassia (alpha 1-proteinase inhibitor (75N90021P00727), from NIH Clinical Center, on September 17, 2021.
On GovTribe
See Baxalta US Inc.'s full federal record
- Federal contract awards
- IDV awards
- Contract vehicles
- Funding analysis by agency, NAICS and set-aside
- Similar vendors